Hydroxychloroquine: A relatively obscure antimalarial takes centre stage in COVID-19

Padmanaban, G and Nagaraj, VA (2020) Hydroxychloroquine: A relatively obscure antimalarial takes centre stage in COVID-19. In: Current Science, 118 (10). pp. 1489-1491.

PDF CUR_SCI_118_10_1489-1491_2020.pdf - Published Version Restricted to Registered users only Download (429kB) | Request a copy

Abstract

Hydroxychloroquine (HCQ) is an old antimalarial known for its use to treat rheumatoid arthritis. Recently, it has been shown to be useful in COVID-19 treatment, although its efficacy is being debated and the data from large-scale clinical trials are yet to be available. Overall, it appears that HCQ-Azithromycin-Remdesevir may be a viable treatment option on a case to case basis. There is also a case to evaluate curcumin as an adjunct food supplement to prevent and treat COVID-19. © 2020, Indian Academy of Sciences.

Item Type:	Editorials/Short Communications
Publication:	Current Science
Publisher:	Indian Academy of Sciences
Additional Information:	Copy right for this article belongs to Indian Academy of Sciences
Department/Centre:	Division of Biological Sciences > Biochemistry
Date Deposited:	11 Nov 2020 10:52
Last Modified:	11 Dec 2022 04:43
URI:	https://eprints.iisc.ac.in/id/eprint/65724

Actions (login required)

View Item